← Moderna, Inc.

Moderna, Inc.

MRNA Revenue

Quarterly revenue, the top-line sales a company books before any costs are subtracted.

Latest Revenue: $145M (2026Q2); +2.1% YoY; -54.4% CAGR (3.25y).

Across the 14 quarters from 2023Q1 to 2026Q2, Revenue ranged from $108M in 2025Q1 to $2.81B in 2023Q4.

Revenue EPS Free Cash Flow Gross Margin FCF Margin Cumulative FCF Rule of 40
MRNA Revenue

Latest: $145M (2026Q2)

Healthcare Comparison

1 / 3

Other MRNA Charts

More quarter-by-quarter fundamentals for Moderna, Inc.

1 / 6